Pfizer Makes $100 Billion Approach to AstraZeneca

The Wall Street Journal
April 28, 2014 AT 10:35 AM
Pfizer confirmed Monday that it made a renewed approach to AstraZeneca regarding a takeover valued at nearly $100 billion, but the U.K.-listed pharmaceutical firm had declined to engage in talks. Dana Cimilluca joins MoneyBeat.